# Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

> **NCT02140489** · PHASE1 · UNKNOWN · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** amosartan
- **DRUG:** rosuvastatin
- **DRUG:** amosartan and rosuvastatin

## Key facts

- **NCT ID:** NCT02140489
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140489, "Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02140489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*